Home › Funds › BANTAMAC CAPITAL, LLC › ABBV

BANTAMAC CAPITAL, LLC position in ABBV

ABBVIE INC · Health Care

BANTAMAC CAPITAL, LLC reported holding 3,580 shares of ABBV (ABBVIE INC) in its Q2 2026 13F filing — a position valued at US$901K, representing 0.70% of its reported portfolio and ranking #24 among its reported holdings. BANTAMAC CAPITAL, LLC has disclosed ABBV holdings in 12 of the last 12 reported quarters, going back to Q3 2023.

Latest position (Q2 2026)3.58K sh
Reported value held$900.87K
Portfolio Weight0.70%
First reportedQ3 2023
Last changeReduce
Updated2026-10-24

Last updated: 2026-10-24 · Source: SEC EDGAR Form 13F-HR

How BANTAMAC CAPITAL, LLC's ABBV position evolved

BANTAMAC CAPITAL, LLC first disclosed a stake in ABBV in Q3 2023 at 8,709 shares (US$1.3M). The position peaked in Q4 2023 at 8,511 shares, worth US$1.3M. Across 12 filings, BANTAMAC CAPITAL, LLC increased the stake 3 time(s), trimmed it 4 time(s) and left it unchanged 4 time(s). The most recent filing (Q2 2026) shows 3,580 shares valued at US$901K — a reduction of -81 shares quarter over quarter.. Notable position changes include a 55% trim in Q1 2024 (shares fell 5% over the following quarter), a 95% trim in Q4 2024 (shares rose 19% over the following quarter), a 1730% increase in Q4 2025 (shares fell 4% over the following quarter).

Quarter by quarter

QuarterSharesValueChange
Q3 2023 8.71K $1.30M New
Q4 2023 8.51K $1.32M Reduce
Q1 2024 3.83K $697.10K Reduce
Q2 2024 4.23K $725.72K Add
Q3 2024 4.43K $874.86K Add
Q4 2024 200 $35.54K Reduce
Q1 2025 200 $41.90K Hold
Q2 2025 200 $37.12K Hold
Q3 2025 200 $46.31K Hold
Q4 2025 3.66K $836.39K Add
Q1 2026 3.66K $796.23K Hold
Q2 2026 3.58K $900.87K Reduce

Dots on the line are colored by change type; missing quarters mean no position was reported.

About ABBV and 13F data

ABBV (ABBVIE INC) is a Health Care company. 35 other funds we track also report a position in ABBV — the largest reported positions include Vanguard Group (US$41.31B), BlackRock Inc (US$37.62B), VANGUARD CAPITAL MANAGEMENT LLC (US$29.04B). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding ABBV

All ABBV fund holders →

FAQ

How long has BANTAMAC CAPITAL, LLC held ABBV?

BANTAMAC CAPITAL, LLC has disclosed ABBV holdings in 12 of the last 12 reported quarters, going back to Q3 2023.

What is BANTAMAC CAPITAL, LLC's current position in ABBV?

As of Q2 2026, BANTAMAC CAPITAL, LLC holds 3.58K shares of ABBV (ABBVIE INC), valued at $900.87K, representing 0.70% of its reported portfolio and ranking #24.

Has BANTAMAC CAPITAL, LLC been buying or selling ABBV?

In the latest 13F filing (Q2 2026), BANTAMAC CAPITAL, LLC reduced its position in ABBV. The position peaked in Q4 2023 at 8.51K shares.

Which other funds hold ABBV?

Other major institutional holders of ABBV include Vanguard Group, BlackRock Inc, VANGUARD CAPITAL MANAGEMENT LLC, among 35 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.